These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 21040946)

  • 1. Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures.
    Sim WJ; Lee JW; Lee ES; Shin SK; Hwang SR; Oh JE
    Chemosphere; 2011 Jan; 82(2):179-86. PubMed ID: 21040946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of fates of estrogens in wastewater and sludge from various types of wastewater treatment plants.
    Sim WJ; Lee JW; Shin SK; Song KB; Oh JE
    Chemosphere; 2011 Mar; 82(10):1448-53. PubMed ID: 21146855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence and fate of pharmaceuticals in wastewater treatment plants and rivers in Korea.
    Sim WJ; Lee JW; Oh JE
    Environ Pollut; 2010 May; 158(5):1938-47. PubMed ID: 19913963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of pharmaceuticals in secondary wastewater treatment processes in Taiwan.
    Lin AY; Yu TH; Lateef SK
    J Hazard Mater; 2009 Aug; 167(1-3):1163-9. PubMed ID: 19269086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The occurrence of illicit and therapeutic pharmaceuticals in wastewater effluent and surface waters in Nebraska.
    Bartelt-Hunt SL; Snow DD; Damon T; Shockley J; Hoagland K
    Environ Pollut; 2009 Mar; 157(3):786-91. PubMed ID: 19110357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain).
    Santos JL; Aparicio I; Alonso E
    Environ Int; 2007 May; 33(4):596-601. PubMed ID: 17084895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results.
    Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
    Environ Pollut; 2009 May; 157(5):1721-6. PubMed ID: 19201071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China.
    Sui Q; Huang J; Deng S; Yu G; Fan Q
    Water Res; 2010 Jan; 44(2):417-26. PubMed ID: 19674764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of sulfonamide residues along the Ebro River basin: removal in wastewater treatment plants and environmental impact assessment.
    García-Galán MJ; Díaz-Cruz MS; Barceló D
    Environ Int; 2011 Feb; 37(2):462-73. PubMed ID: 21183221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece.
    Kosma CI; Lambropoulou DA; Albanis TA
    J Hazard Mater; 2010 Jul; 179(1-3):804-17. PubMed ID: 20395039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of pharmaceuticals in Taiwan's surface waters: impact of waste streams from hospitals and pharmaceutical production facilities.
    Lin AY; Tsai YT
    Sci Total Environ; 2009 Jun; 407(12):3793-802. PubMed ID: 19345984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of estrogenic activity in surface water and municipal wastewater in Shanghai, China.
    Yang M; Wang K; Shen Y; Wu M
    Bull Environ Contam Toxicol; 2011 Sep; 87(3):215-9. PubMed ID: 21735275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass flows and removal of antibiotics in two municipal wastewater treatment plants.
    Li B; Zhang T
    Chemosphere; 2011 May; 83(9):1284-9. PubMed ID: 21439606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of pharmaceutically active compounds during 1-year period in wastewaters from four wastewater treatment plants in Seville (Spain).
    Santos JL; Aparicio I; Callejón M; Alonso E
    J Hazard Mater; 2009 May; 164(2-3):1509-16. PubMed ID: 18990491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of pharmaceuticals and personal care products contamination along the river Somes watershed, Romania.
    Moldovan Z; Schmutzer G; Tusa F; Calin R; Alder AC
    J Environ Monit; 2007 Sep; 9(9):986-93. PubMed ID: 17726560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of androgens and progestogens in wastewater treatment plants and receiving river waters: comparison to estrogens.
    Chang H; Wan Y; Wu S; Fan Z; Hu J
    Water Res; 2011 Jan; 45(2):732-40. PubMed ID: 20850861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment.
    Jelic A; Gros M; Ginebreda A; Cespedes-Sánchez R; Ventura F; Petrovic M; Barcelo D
    Water Res; 2011 Jan; 45(3):1165-76. PubMed ID: 21167546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence and reduction of pharmaceuticals in the water phase at Swedish wastewater treatment plants.
    Falås P; Andersen HR; Ledin A; la Cour Jansen J
    Water Sci Technol; 2012; 66(4):783-91. PubMed ID: 22766867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the diurnal variability of pharmaceutical and personal care products in a full-scale activated sludge plant.
    Salgado R; Marques R; Noronha JP; Mexia JT; Carvalho G; Oehmen A; Reis MA
    Environ Pollut; 2011 Oct; 159(10):2359-67. PubMed ID: 21783287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of 65 pharmaceuticals and personal care products in 5 wastewater treatment plants in Portugal using a simplified analytical methodology.
    Salgado R; Noronha JP; Oehmen A; Carvalho G; Reis MA
    Water Sci Technol; 2010; 62(12):2862-71. PubMed ID: 21123916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.